People living with this rare blood cancer often deal with complex and unpredictable symptoms. Connecting with support and ...

It was Jan. 18, and FIU softball coach Mike Larabee had just finished conducting practice. He gathered his team on the grass in right field and told them he was going to miss the 2025 season due to ...

A live audio webcast of the fireside chat presentation will be available at https://wsw.com/webcast/guggen2/kros/2033361 and an archived replay will be accessible in the Investors section of the Keros ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

The movie adaptation of Tomi Adeyemi's debut YA novel, Children of Blood and Bone, is officially on the horizon. After years in the making, it looks like the literary phenomenon is finally ...

Allogenic haematopoietic stem cell transplantation (allo-HSCT) can induce bone marrow fibrosis regression in patients with myelofibrosis (MF) however, the effect on the skeleton is unclear.

Larabee, the school said, has been diagnosed with myelofibrosis. According to the Mayo Clinic, myelofibrosis is a chronic leukemia — a rare cancer that affects bone marrow. “FIU softball is in great ...

Larabee, the school said, has been diagnosed with myelofibrosis. According to the Mayo Clinic, myelofibrosis is a chronic leukemia -- a rare cancer that affects bone marrow. "FIU softball is in great ...

The risks of developing bone marrow fibrosis, malignancy, and thrombosis with romiplostim and the risk of developing more severe thrombocytopenia than at pretreatment after drug discontinuation ...

FIU softball coach Mike Larabee stepped down on Saturday after being diagnosed with a form of blood cancer. Larabee's absence is expected to last for the entirety of the 2025 season, which starts Feb.

MIAMI (AP) — FIU softball coach Mike Larabee stepped down Saturday after being diagnosed with a form of blood cancer. Larabee’s absence is expected to last for the entirety of the season ...

There are hopes it could be listed on the Pharmaceutical Benefits Scheme by the end of the year, making it more affordable for myelofibrosis patients like Deb Fryers. (Nine) Property News ...